AI and Nanotechnology Enable Five Minute Drug Screening from a Single Drop of Urine
en-GBde-DEes-ESfr-FR

AI and Nanotechnology Enable Five Minute Drug Screening from a Single Drop of Urine


As drug-related crime rises rapidly worldwide, the need for fast, reliable technologies that can identify illicit drug use at the point of testing is becoming increasingly urgent.

Laboratory testing can provide accurate results, but it requires multiple sample preparation steps and specialized analytical equipment. In contrast, rapid on-site test kits offer faster results, yet their accuracy was limited by factors such as insufficient volume and cross-reactivity with structrually similar drugs.

A research team led by Dr. Eun-Kyung Lim at the Bionanotechnology Research Center of the Korea Research Institute of Bioscience and Biotechnology (KRIBB) has developed a platform that combines nanotechnology and artificial intelligence to screen urine for illicit drug use within five minutes, without chemical pretreatment. The study was conducted in collaboration with Professor Tae Hwan Kim at Daegu Catholic University, Professor Joon Hee Lee at Seoul National University Bundang Hospital, and the AI Research Center at StoneLab.

The researchers developed a nanostructured substrate that amplifies the faint light signals produced by drug molecules by millions of times or more. They formed densely packed, grass-like nanopillars on a thin gold surface and roughened their surfaces by selective etching. When drug molecules settle on the substrate, their characteristic vibrational light signals become much stronger, allowing even trace amounts to be clearly identified.

The team also used an artificial intelligence model called LightGBM to distinguish the unique signal fingerprints of illicit drugs from the complex background signals in urine. This approach addresses a longstanding challenge: identifying drug-specific signals in samples containing a wide range of metabolic waste products and medication metabolites.

In tests using real urine specimens, the AI-assisted platform identified drug-positive samples with approximately 80% accuracy, even among urine samples from patients taking non-narcotic analgesics or multiple medications. In experiments with rats, the researchers further demonstrated that drug components could be analyzed in urine collected within six hours after administration.

The findings establish a core technology for rapid, precise on-site drug screening using a single drop of urine without sample pretreatment. The approach brings together advantages of large laboratory instruments and rapid test kits.

With further development into a compact, portable measurement device, the platform could be used in medical and forensic settings, including on-site drug screening by law enforcement agencies and rapid assessment of drug intoxication in hospital emergency departments.

"This study demonstrates that combining nanoengineering with explainable AI algorithms can enable rapid, precise classification of illicit drugs even in complex bodily fluids," said Dr. Eun-Kyung Lim, who led the study. "By further developing the platform into a portable diagnostic device for on-site use, we hope to transform drug screening and emergency diagnostics."

The study was published in September 2026 in ACS Measurement Science Au (Impact Factor: 14.7), an international scientific journal.

The article is titled "Interpretable Screening of Illicit Drugs in Raw Urine via LightGBM-Assisted SERS" (2026). The corresponding authors are Dr. Eun-Kyung Lim of KRIBB, Professor Tae Hwan Kim of Daegu Catholic University, and Professor Joon Hee Lee of Seoul National University Bundang Hospital. Dr. Jinyoung Kim of KRIBB is a first author.

This research was supported by the Institute of Information & Communications Technology Planning & Evaluation (IITP), the Korea Planning & Evaluation Institute of Industrial Technology (KEIT), the Korea Health Industry Development Institute (KHIDI), the Korea Medical Device Development Fund (KMDF), the National Research Council of Science & Technology (NST), the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET), the National Research Foundation of Korea (NRF), and the Major Research Programs of KRIBB.
Journal: ACS Measurement Science Au
Title: Interpretable Screening of Illicit Drugs in Raw Urine via LightGBM-Assisted SERS
Date: September 24, 2026
DIO: https://doi.org/10.1021/acsmeasuresciau.6c00234
Archivos adjuntos
  • Schematic illustration of raw urinary drug screening process via SERS integrated with a LightGBM framework.
  • Photo of the research team (from left: Dr. Jinyoung Kim, Principal Researcher Eunkyung Lim)
  • Photograph of the as-synthesized substrate
Regions: Asia, South Korea
Keywords: Applied science, Technology, Artificial Intelligence, Nanotechnology, Health, Well being

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement